A Decade-Long Cohort Analysis of Human Cytomegalovirus (HCMV)-Induced Early and Late Renal Rejection in Post-Transplant Patients in the Eastern Indian Population
- PMID: 38932140
- PMCID: PMC11209308
- DOI: 10.3390/v16060847
A Decade-Long Cohort Analysis of Human Cytomegalovirus (HCMV)-Induced Early and Late Renal Rejection in Post-Transplant Patients in the Eastern Indian Population
Abstract
Background: HCMV causes severe clinical complications in transplant recipients and may lead to graft rejection. Successful renal transplantation heavily relies on the early prevention and diagnosis of CMV infections, followed by prompt prophylactic treatment before transplantation. Despite the majority of renal rejection cases with acute HCMV infections being asymptomatic and occurring one to two years later, the objective of this research was to comprehend the effect of late HCMV infection on renal rejection by examining specific clinical parameters in the Eastern Indian cohort. Method: In this study, 240 patients were studied for five years following transplantation, and their data were collected from the local metropolitan hospital in Eastern India. Both HCMV-positive and -negative post-transplant patients were investigated using the clinical parameters and viral loads for latent infection. Results: Within the studied population, 79 post-transplant patients were found to be HCMV positive. Among them, 13 (16.45%) patients suffered from renal rejection within less than 2 yrs. of transplantation (early rejection) and 22 (27.84%) patients suffered from renal rejection after 2 yrs. from the operation date (late rejection). Assessment of clinical parameters with respect to HCMV infection revealed that in early rejection cases, fever (p-0.035) and urinary tract infection (p-0.017) were prominent, but in late rejection, hematuria (p-0.032), diabetes (p-0.005), and creatinine level changes (p < 0.001) were significant along with urinary tract infection (p-0.047). Conclusions: This study provides valuable insights into monitoring latent CMV infections and highlights the understanding of reducing renal rejection rates and the need for further research in this field.
Keywords: clinical outcome; human cytomegalovirus; latent infection; renal rejection.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.Transpl Int. 2000;13(6):413-9. doi: 10.1007/s001470050723. Transpl Int. 2000. PMID: 11140239
-
Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.Chin Med J (Engl). 2012 Oct;125(19):3575-7. Chin Med J (Engl). 2012. PMID: 23044327
-
HCMV infection in renal transplant recipients: a retrospective cohort study.New Microbiol. 2013 Oct;36(4):363-71. Epub 2013 Oct 1. New Microbiol. 2013. PMID: 24177298
-
The impact of early cytomegalovirus infection and disease in renal transplant recipients.Clin Microbiol Infect. 2005 Jul;11(7):518-30. doi: 10.1111/j.1469-0691.2005.01190.x. Clin Microbiol Infect. 2005. PMID: 15966969 Review.
-
Monitoring transplant patients for human cytomegalovirus: Diagnostic update.Herpes. 2006 May;13(1):4-11. Herpes. 2006. PMID: 16732996 Review.
References
-
- Selvey L.A., Lim W.H., Boan P., Swaminathan R., Slimings C., Harrison A.E., Chakera A. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience. BMC Infect. Dis. 2017;17:501. doi: 10.1186/S12879-017-2599-Y. - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical